LusoBioMaker: A low-cost 3D bioprinter with multi-extrusion and contour printing capabilities for thermo- and photocurable hydrogels towards complex tissue fabrication

Q1 Computer Science
Afonso Gusmão , Diana M.C. Marques , Duarte Almeida , Kristin Schüler , Frederico Castelo Ferreira , Paola Sanjuan-Alberte , Marco Leite
{"title":"LusoBioMaker: A low-cost 3D bioprinter with multi-extrusion and contour printing capabilities for thermo- and photocurable hydrogels towards complex tissue fabrication","authors":"Afonso Gusmão ,&nbsp;Diana M.C. Marques ,&nbsp;Duarte Almeida ,&nbsp;Kristin Schüler ,&nbsp;Frederico Castelo Ferreira ,&nbsp;Paola Sanjuan-Alberte ,&nbsp;Marco Leite","doi":"10.1016/j.bprint.2025.e00425","DOIUrl":null,"url":null,"abstract":"<div><div>3D bioprinting is an expanding field that allows for the design of intricate structures using multiple materials and living cells. This has enormous potential for applications in drug testing, regenerative medicine, and, more recently, cell-based food products, with the surge of the cellular agriculture field. However, the high cost of equipment is frequently a significant limitation for implementing these approaches. Here, we present LusoBioMaker, an open-source bioprinter that delivers commercial-grade performance for under $900 of materi. Built on a modified Ender 3-V2 platform it integrates dual screw-driven extrusion, independent active temperature control (2–50 °C) and in-situ 365 nm photocuring, generating up to 320 N force through open-access firmware. Using κ-carrageenan, Pluronic F-127 and gelatin methacrylate/poly(ethyleneglycol) diacrylate (GelMA/PEGDA) inks we printed complex lattices with a printability factor of 0.995 and sub-millimetre dimensional errors while maintaining 97 % L929 cell viability after fourteen days. Comprehensive calibration and acceptance tests performed in accordance with the ISO 230-1/2 standards confirmed &lt;50 μm positional error and &lt;0.005° angular deviation across both extrusion nozzles. A systematic review of 17 reported low-cost bioprinters revealed that none combine dual screw extrusion, active thermal regulation and on-head UV curing in a single chassis, highlighting LusoBioMaker's unique features set. As a proof-of-concept, we bioprinted a hollow nipple–areola complex by co-extruding a thermosensitive κ-carrageenan core and a photocurable GelMA/PEGDA shell, exploiting all three hardware capabilities in one uninterrupted run. This demonstration underscores LusoBioMaker's capacity to manufacture anatomically intricate, gradient tissues on demand and to democratise advanced biofabrication workflows.</div></div>","PeriodicalId":37770,"journal":{"name":"Bioprinting","volume":"50 ","pages":"Article e00425"},"PeriodicalIF":0.0000,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioprinting","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405886625000417","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Computer Science","Score":null,"Total":0}
引用次数: 0

Abstract

3D bioprinting is an expanding field that allows for the design of intricate structures using multiple materials and living cells. This has enormous potential for applications in drug testing, regenerative medicine, and, more recently, cell-based food products, with the surge of the cellular agriculture field. However, the high cost of equipment is frequently a significant limitation for implementing these approaches. Here, we present LusoBioMaker, an open-source bioprinter that delivers commercial-grade performance for under $900 of materi. Built on a modified Ender 3-V2 platform it integrates dual screw-driven extrusion, independent active temperature control (2–50 °C) and in-situ 365 nm photocuring, generating up to 320 N force through open-access firmware. Using κ-carrageenan, Pluronic F-127 and gelatin methacrylate/poly(ethyleneglycol) diacrylate (GelMA/PEGDA) inks we printed complex lattices with a printability factor of 0.995 and sub-millimetre dimensional errors while maintaining 97 % L929 cell viability after fourteen days. Comprehensive calibration and acceptance tests performed in accordance with the ISO 230-1/2 standards confirmed <50 μm positional error and <0.005° angular deviation across both extrusion nozzles. A systematic review of 17 reported low-cost bioprinters revealed that none combine dual screw extrusion, active thermal regulation and on-head UV curing in a single chassis, highlighting LusoBioMaker's unique features set. As a proof-of-concept, we bioprinted a hollow nipple–areola complex by co-extruding a thermosensitive κ-carrageenan core and a photocurable GelMA/PEGDA shell, exploiting all three hardware capabilities in one uninterrupted run. This demonstration underscores LusoBioMaker's capacity to manufacture anatomically intricate, gradient tissues on demand and to democratise advanced biofabrication workflows.
LusoBioMaker:一种低成本的生物3D打印机,具有多挤出和轮廓打印能力,可用于热固化和光固化水凝胶,用于复杂的组织制造
3D生物打印是一个不断发展的领域,它允许使用多种材料和活细胞设计复杂的结构。随着细胞农业领域的蓬勃发展,这在药物测试、再生医学以及最近以细胞为基础的食品方面具有巨大的应用潜力。然而,设备的高成本往往是实施这些方法的一个重大限制。在这里,我们介绍LusoBioMaker,一个开源的生物打印机,提供商业级的性能低于900美元的材料。它建立在改进的Ender 3-V2平台上,集成了双螺杆驱动挤出,独立主动温度控制(2-50°C)和365 nm原位光固化,通过开放获取固件产生高达320 N的力。我们使用κ-卡拉胶、Pluronic F-127和甲基丙烯酸明胶/聚乙二醇二丙烯酸酯(GelMA/PEGDA)油墨打印复杂晶格,打印因子为0.995,尺寸误差为亚毫米,14天后L929细胞存活率保持在97%。根据ISO 230-1/2标准进行的全面校准和验收测试确认,两个挤出喷嘴的位置误差为50 μm,角偏差为0.005°。对17种低成本生物打印机的系统回顾显示,没有一种将双螺杆挤出、主动热调节和头部UV固化结合在一个机箱中,这突出了LusoBioMaker的独特功能。作为概念验证,我们通过共挤出热敏的β -卡拉胶核和光固化的GelMA/PEGDA壳,在一次不间断的运行中利用了所有三种硬件功能,打印出了空心乳头-乳晕复合物。这次演示强调了LusoBioMaker的能力,以制造解剖复杂,梯度组织的需求和民主化先进的生物制造工作流程。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Bioprinting
Bioprinting Computer Science-Computer Science Applications
CiteScore
11.50
自引率
0.00%
发文量
72
审稿时长
68 days
期刊介绍: Bioprinting is a broad-spectrum, multidisciplinary journal that covers all aspects of 3D fabrication technology involving biological tissues, organs and cells for medical and biotechnology applications. Topics covered include nanomaterials, biomaterials, scaffolds, 3D printing technology, imaging and CAD/CAM software and hardware, post-printing bioreactor maturation, cell and biological factor patterning, biofabrication, tissue engineering and other applications of 3D bioprinting technology. Bioprinting publishes research reports describing novel results with high clinical significance in all areas of 3D bioprinting research. Bioprinting issues contain a wide variety of review and analysis articles covering topics relevant to 3D bioprinting ranging from basic biological, material and technical advances to pre-clinical and clinical applications of 3D bioprinting.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信